What's new

[PIO] Every report to the Ministry of Health's Pharmaceutical Services helps improve the safety of medicines for all patients

31211.jpg




As part of the #MedSafetyWeek campaign on Social Media, the public is encouraged to report suspected adverse reactions after taking medicines.

The seventh annual #MedSafetyWeek campaign, announced today by the Pharmaceutical Services, runs from 7 - 13 November and aims to encourage all members of the public to report suspected adverse reactions after taking medicines. The annual global campaign, which involves pharmacovigilance authorities in 82 countries, focuses on the key role of every healthcare professional, patient and carer to report suspected adverse reactions and thus contribute to the safe use of medicines.

All medicines can cause adverse reactions in some patients and therefore measures are in place to continuously monitor their safety after they have been placed on the market. The purpose of safety monitoring is to obtain more information on known adverse reactions, as well as to identify and evaluate new side effects. Regulatory authorities operate systems to identify and analyse these adverse events, and thus prevent harm to future patients.

The National Yellow Card Reporting System, managed by the Pharmacovigilance Division of the Pharmaceutical Services, collects, organises and investigates reports of suspected adverse events. Since its implementation, the system has helped identify several safety issues that were not previously identified as having an association with specific medicines until the Services received relevant information from reports.

By reporting suspected adverse events to the national Yellow Card reporting system, citizens are actively involved in identifying emerging safety issues so that the relevant authorities can take action when necessary and protect others from harm.

Pharmaceutical Services notes the following:

- Every report made by a patient, healthcare professional or carer plays a key role in enriching knowledge about the benefits and risks of medicines in clinical practice and enables action to be taken to minimise risks.

- Reporting suspected adverse events in the national Yellow Card reporting system helps to enhance the safety of medicines for all patients and, in some cases, can lead to optimal tailored prescribing recommendations that can improve patient outcomes.

- If you or a patient experiences a side effect with a drug, be sure to report it to us immediately.

- Anyone can report suspected adverse reactions to Pharmaceutical Services through the national reporting system.

Recall that adverse reactions can be reported under the national reporting system to the Pharmaceutical Services, Pharmacovigilance Sector, by submitting the Yellow Card in the following ways:

- Electronic submission via the Pharmaceutical Services website www.moh.gov.cy/phs and directly at www.kitrinikarta.gov.cy

- Sending a hard copy by fax (22-608669) or by post to the Pharmacovigilance Sector, Pharmaceutical Services (Polyfimou 15, 2033 Strovolos).

Notes:


[*]The national pharmacoregulatory authorities of 82 countries around the world as well as stakeholders are participating in the international information campaign under the auspices of the Uppsala Monitoring Centre (UMC) of the World Health Organization (WHO). The campaign is supported by the members of the International Coalition of Medicines Regulatory Authorities (ICMRA). [*] The Pharmaceutical Services of the Ministry of Health are involved in protecting and improving the health of millions of people every day through the effective regulation of all vaccines and medicines in the Republic of Cyprus and ensuring their efficacy and safety. This work is based on a thorough scientific evaluation of the available efficacy and safety data to ensure in each case that the benefits outweigh the risks. [*]Patients are encouraged to contact a healthcare professional if they have any concerns about their health.

(AF)
Contents of this article including associated images are owned by PIO
Views & opinions expressed are those of the author and/or PIO

Source

[/P]
 
Back
Top